Anke Morgner
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Neurology top 5%
- CNS Lymphoma Diagnosis and Treatment
Papers in
- Hematology 13
- Acute Myeloid Leukemia Research 8
- Hematopoietic Stem Cell Transplantation 4
- Multiple Myeloma Research and Treatments 4
-
- CNS Lymphoma Diagnosis and Treatment 4
- Co-authors
- Julie Alaere Atta (1 shared paper)Jürgen Finke (2 shared papers)Martin H. Dreyling (1 shared paper)Thomas Burmeister (1 shared paper)Benjamin Kasenda (2 shared papers)Stefan W. Krause (2 shared papers)Gerald Illerhaus (2 shared papers)Norbert Frickhofen (1 shared paper)
- Journals
- Blood (5 papers)Blood Advances (3 papers)Leukemia (3 papers)HemaSphere (2 papers)Transplantation and Cellular Therapy (2 papers)
- Partner nations
- GermanySwitzerland
In The Last Decade
Anke Morgner
23 papers receiving 788 citations
Anke Morgner's Hit Papers
Peers
Comparison fields: 5 of 33
- Hematology 235
- Neurology 197
- Immunology 187
- Public Health, Environmental and Occupational Health 108
- Infectious Diseases 45
Countries citing papers authored by Anke Morgner
This map shows the geographic impact of Anke Morgner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anke Morgner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anke Morgner more than expected).
Fields of papers citing papers by Anke Morgner
This network shows the impact of papers produced by Anke Morgner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anke Morgner. The network helps show where Anke Morgner may publish in the future.
Co-authors
The 25 scholars most cited alongside Anke Morgner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 139 | |
| 2 | 2020 | 100 | |
| 3 | Real-world analysis of teclistamab in 123 RRMM patients from Germany Hit paper breakdown → | 2024 | 74 |
| 4 | 2013 | 72 | |
| 5 | 2012 | 70 | |
| 6 | 2020 | 60 | |
| 7 | 2021 | 55 | |
| 8 | 2022 | 49 | |
| 9 | 2023 | 34 | |
| 10 | 2010 | 30 | |
| 11 | 2015 | 30 | |
| 12 | 2001 | 22 | |
| 13 | 2017 | 11 | |
| 14 | 2022 | 10 | |
| 15 | 2024 | 9 | |
| 16 | 2012 | 8 | |
| 17 | 2015 | 8 | |
| 18 | 2019 | 7 | |
| 19 | 2024 | 3 | |
| 20 | 2023 | 2 |
About Anke Morgner
Anke Morgner is a scholar working on Hematology, Neurology, Immunology, Infectious Diseases and Public Health, Environmental and Occupational Health, having authored 25 papers that have together received 797 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (8 papers), Hematopoietic Stem Cell Transplantation (4 papers), Multiple Myeloma Research and Treatments (4 papers), CNS Lymphoma Diagnosis and Treatment (4 papers), Complement system in diseases (3 papers), Acute Lymphoblastic Leukemia research (3 papers), COVID-19 Clinical Research Studies (2 papers) and SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Hematology (235 citations), Neurology (197 citations), Immunology (187 citations), Public Health, Environmental and Occupational Health (108 citations) and Infectious Diseases (45 citations). Anke Morgner has collaborated with scholars based in Germany and Switzerland. Frequent co-authors include Julie Alaere Atta, Jürgen Finke, Martin H. Dreyling, Thomas Burmeister, Benjamin Kasenda, Stefan W. Krause, Gerald Illerhaus, Norbert Frickhofen, Beate C. Klimm and Monika Brüggemann. Their work appears in journals such as Blood, Blood Advances, Leukemia, HemaSphere and Transplantation and Cellular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.